• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病死亡率的变化模式。

The changing patterns of death rates in parkinsonism.

作者信息

Kurtzke J F, Murphy F M

机构信息

Neuroepidemiology Research Program, Veterans Administration Medical Center, Washington, DC 20422.

出版信息

Neurology. 1990 Jan;40(1):42-9. doi: 10.1212/wnl.40.1.42.

DOI:10.1212/wnl.40.1.42
PMID:2296381
Abstract

Annual crude death rates due to parkinsonism in Denmark, 1956 to 1985, and the United States, 1950 to 1984, showed a consistent hierarchy, with white male rates greater than white female than black male than black female. Rates rose sharply in both lands and sexes between 1976 and 1984. Age-specific death rate curves for whites in the 1960s and 1980s were very similar between the countries with a regular male excess. Both countries drastically changed the configuration of all the death rate age curves in parallel fashion between the 2 periods: rates were now nearly twice those of the earlier interval for each sex, age, and race, and were then maximal at age 82 or 85+ as opposed to the prior peak at age 77 or 80. Age-adjusted rates did not consistently reflect this change, being markedly lower for US white females despite their age-specific rate increases. This discrepancy appears to be an artifact of changing population distributions which increasingly differ by age between sexes and countries over time. When the recent age-specific death rates were recalculated with the thesis that all deaths had occurred at ages 5 years younger, all the 1980s death rate configurations returned to those of the 1960s, with but modest increases at most ages. This is evidence that age at death, and thus survival, has increased at all ages by about 5 years since the introduction of levodopa, released in the US in 1970 and in Denmark in 1971.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1956年至1985年丹麦以及1950年至1984年美国帕金森病的年粗死亡率呈现出一致的层级关系,即白人男性死亡率高于白人女性,高于黑人男性,高于黑人女性。1976年至1984年间,两国各性别死亡率均急剧上升。20世纪60年代和80年代,两国白人的年龄别死亡率曲线非常相似,男性死亡率均持续偏高。在这两个时期之间,两国所有死亡率年龄曲线的形态都以平行方式发生了巨大变化:现在各性别、年龄和种族的死亡率几乎是早期的两倍,之前死亡率峰值出现在77岁或80岁,现在则出现在82岁或85岁以上。年龄调整后的死亡率并未始终反映出这种变化,美国白人女性的年龄调整后死亡率明显较低,尽管其年龄别死亡率有所上升。这种差异似乎是人口分布变化的产物,随着时间推移,不同性别和国家之间的年龄差异越来越大。当按照所有死亡都提前5年发生的假设重新计算近期的年龄别死亡率时,20世纪80年代所有死亡率曲线形态都恢复到了20世纪60年代的形态,大多数年龄段的死亡率最多只有适度上升。这表明,自1970年在美国和1971年在丹麦推出左旋多巴以来,各年龄段的死亡年龄(即生存时间)都增加了约5年。(摘要截选至250词)

相似文献

1
The changing patterns of death rates in parkinsonism.帕金森病死亡率的变化模式。
Neurology. 1990 Jan;40(1):42-9. doi: 10.1212/wnl.40.1.42.
2
Mortality rates for parkinsonism in Italy (1969 to 1987).意大利帕金森症的死亡率(1969年至1987年)。
Acta Neurol Scand. 1993 Jan;87(1):9-13. doi: 10.1111/j.1600-0404.1993.tb04067.x.
3
The effect of revised populations on mortality statistics for the United States, 2000.2000年美国人口修订对死亡率统计数据的影响。
Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24.
4
Parkinsonism death rates by race, sex, and geography.按种族、性别和地理位置划分的帕金森病死亡率。
Neurology. 1988 Oct;38(10):1558-61. doi: 10.1212/wnl.38.10.1558.
5
Parkinsonism death rates by race, sex and geography: a 1980s update.按种族、性别和地理位置划分的帕金森氏症死亡率:20世纪80年代的最新情况
Neuroepidemiology. 1990;9(5):243-7. doi: 10.1159/000110780.
6
Sex differentials in health and mortality.健康与死亡率方面的性别差异。
Women Health. 1987;12(2):103-45. doi: 10.1300/J013v12n02_07.
7
Epidemiology of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的流行病学
Adv Neurol. 1982;36:281-302.
8
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
9
Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data.1979 - 1990年美国克雅氏病的流行病学:国家死亡率数据分析
Neuroepidemiology. 1995;14(4):174-81. doi: 10.1159/000109793.
10
Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990.1950年至1990年期间结直肠癌发病率、生存率和死亡率的时间模式。
J Natl Cancer Inst. 1994 Jul 6;86(13):997-1006. doi: 10.1093/jnci/86.13.997.

引用本文的文献

1
Mortality in levodopa-treated Parkinson's disease.左旋多巴治疗的帕金森病患者的死亡率。
Parkinsons Dis. 2014;2014:426976. doi: 10.1155/2014/426976. Epub 2014 Jan 28.
2
Validity of mortality data for Parkinson's disease.帕金森病死亡率数据的有效性。
J Epidemiol Community Health. 1999 Sep;53(9):587-8. doi: 10.1136/jech.53.9.587.
3
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.悉尼帕金森病多中心研究:10年病程及死亡率
J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):300-7. doi: 10.1136/jnnp.67.3.300.
4
Epidemiology of Parkinson's disease.帕金森病的流行病学
Neurol Clin. 1996 May;14(2):317-35. doi: 10.1016/S0733-8619(05)70259-0.
5
Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.神经退行性疾病:1982年至1991年的职业性发病情况及潜在风险因素
Am J Public Health. 1996 Sep;86(9):1281-8. doi: 10.2105/ajph.86.9.1281.
6
How far are we in understanding the cause of Parkinson's disease?在理解帕金森病的病因方面我们进展到什么程度了?
J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):4-16. doi: 10.1136/jnnp.61.1.4.
7
Mortality from Parkinson's disease in England and Wales 1921-89.1921年至1989年英格兰和威尔士帕金森病死亡率。
J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):690-3. doi: 10.1136/jnnp.56.6.690.
8
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.溴隐亭可降低左旋多巴治疗的帕金森病患者的死亡率:普拉多研究已停止。
Eur J Clin Pharmacol. 1992;43(4):357-63. doi: 10.1007/BF02220609.